Boston Trust Walden Corp Amphastar Pharmaceuticals, Inc. Transaction History
Boston Trust Walden Corp
- $13.5 Billion
- Q1 2025
A detailed history of Boston Trust Walden Corp transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Boston Trust Walden Corp holds 1,215,624 shares of AMPH stock, worth $31.6 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
1,215,624
Previous 978,920
24.18%
Holding current value
$31.6 Million
Previous $36.3 Million
3.05%
% of portfolio
0.26%
Previous 0.26%
Shares
3 transactions
Others Institutions Holding AMPH
# of Institutions
257Shares Held
33.6MCall Options Held
20.8KPut Options Held
11.6K-
Black Rock Inc. New York, NY5.94MShares$155 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.42MShares$63 Million0.0% of portfolio
-
Td Asset Management Inc2.21MShares$57.5 Million0.06% of portfolio
-
State Street Corp Boston, MA1.6MShares$41.7 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.36MShares$35.3 Million0.01% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.27B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...